Eli Lilly and Company (LLY): One of the Top Stocks to Buy Right Now According to AI

Eli Lilly and Company (NYSE:LLY) is simply a premier planetary pharmaceutical corp dedicated to discovering, developing, and manufacturing innovative quality medicines crossed aggregate therapeutic areas. The company’s superior maturation catalyst is its world-class cardiometabolic wellness portfolio, led by the highly palmy tirzepatide molecule, marketed arsenic Mounjaro for benignant 2 diabetes and Zepbound for chronic value management. Eli Lilly besides maintains a salient marketplace beingness successful oncology with Jaypirca, immunology with Omvoh and Ebglyss, and neuroscience with Kisunla, an precocious attraction targeting Alzheimer’s disease.

Eli Lilly and Company (NYSE:LLY) relies connected dense reinvestment into objective probe and development, combined with enlargement of planetary manufacturing capacity. The steadfast precocious posted the Q1 2026 fiscal study that recorded full gross of $19.8 billion, representing a 56% year-over-year increase, fueled astir wholly by the request for Mounjaro and Zepbound, which collectively brought successful $12.8 billion. Non-GAAP diluted net per stock skyrocketed by 156% year-over-year to $8.55, vastly exceeding expert forecasts of $6.97. Eli Lilly maintained a superb gross borderline of 82.6%, portion its non-GAAP show borderline expanded by 7 percent points to 50%. Backed by this commercialized momentum, absorption raised its full-year 2026 gross guidance to $82 cardinal to $85 billion.

While we admit the imaginable of LLY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Growth Stock Portfolio: 12 Stock Picks by Carl C. Icahn and Chris Rokos Stock Portfolio: Top 10 Stock Picks.

Disclosure: None. Follow Insider Monkey connected Google News.